Does GLASDEGIB Cause Off label use? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Off label use have been filed in association with GLASDEGIB (Daurismo). This represents 5.6% of all adverse event reports for GLASDEGIB.
29
Reports of Off label use with GLASDEGIB
5.6%
of all GLASDEGIB reports
13
Deaths
7
Hospitalizations
How Dangerous Is Off label use From GLASDEGIB?
Of the 29 reports, 13 (44.8%) resulted in death, 7 (24.1%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLASDEGIB. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does GLASDEGIB Cause?
Death (102)
Febrile neutropenia (86)
Pneumonia (50)
Neoplasm progression (28)
Neutropenia (26)
Electrocardiogram qt prolonged (18)
Sepsis (18)
Pyrexia (17)
Septic shock (16)
Diarrhoea (14)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which GLASDEGIB Alternatives Have Lower Off label use Risk?
GLASDEGIB vs GLATIRAMER
GLASDEGIB vs GLECAPREVIR\PIBRENTASVIR
GLASDEGIB vs GLEEVEC
GLASDEGIB vs GLICLAZIDE
GLASDEGIB vs GLIMEPIRIDE